Cargando…
A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint Regulator()
The identification of SYK as a molecular target in B-lineage leukemia/lymphoma cells prompted the development of SYK inhibitors as a new class of anti-cancer drug candidates. Here we report that induction of the SYK gene expression in human cells causes a significant down-regulation of evolutionaril...
Autores principales: | Uckun, Fatih M., Ma, Hong, Ozer, Zahide, Goodman, Patricia, Zhang, Jian, Qazi, Sanjive |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259291/ https://www.ncbi.nlm.nih.gov/pubmed/25506060 http://dx.doi.org/10.1016/j.ebiom.2014.10.019 |
Ejemplares similares
-
SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Uckun, Fatih M., et al.
Publicado: (2014) -
Get Syk and get cycling
por: Williams, Ruth
Publicado: (2006) -
Regulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase
por: Ma, Hong, et al.
Publicado: (2013) -
SYK Allelic Loss and the Role of Syk-Regulated Genes in Breast Cancer Survival
por: Blancato, Jan, et al.
Publicado: (2014) -
SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)